Summit Therapeutics Inc. Adjustments For Decrease Increase In Trade And Other Receivables
Summit Therapeutics Inc. (SMMT) reported Adjustments For Decrease Increase In Trade And Other Receivables of -GBP 1.24 million for the 3-month period ending 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2020-06-02
- Summit Therapeutics Inc. adjustments for decrease increase in trade and other receivables for the quarter ending 2020-03-31 was -1.24M GBP, a 130.52% decline year-over-year.
- Summit Therapeutics Inc. adjustments for decrease increase in trade and other receivables for the quarter ending 2019-10-31 was 1.26M GBP.
- Summit Therapeutics Inc. adjustments for decrease increase in trade and other receivables for the quarter ending 2019-07-31 was -1.12M GBP, a 201.64% decline year-over-year.
- Summit Therapeutics Inc. adjustments for decrease increase in trade and other receivables for the quarter ending 2019-04-30 was 4.05M GBP.
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 3 month | Adjustments For Decrease Increase In Trade And Other Receivables 6 month | Adjustments For Decrease Increase In Trade And Other Receivables 6 month as first filed | Adjustments For Decrease Increase In Trade And Other Receivables 9 month | Adjustments For Decrease Increase In Trade And Other Receivables 9 month as first filed | Adjustments For Decrease Increase In Trade And Other Receivables 11 month | Adjustments For Decrease Increase In Trade And Other Receivables 12 month | Adjustments For Decrease Increase In Trade And Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -1.24M GBP 6-K · filed 2020-06-02 | |||||||
| 2019-12-31 | 4.66M GBP 20-F · filed 2020-04-30 | |||||||
| 2019-10-31 | 1.26M GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | 139.00K GBP derived: sum of 2 quarters · filed 2019-12-17 | 4.19M GBP 6-K · filed 2019-12-17 | |||||
| 2019-07-31 | -1.12M GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | 2.93M GBP 6-K · filed 2019-10-11 | ||||||
| 2019-04-30 | 4.05M GBP 6-K · filed 2019-06-12 | |||||||
| 2019-03-31 | -30.00K GBP 6-K · filed 2020-06-02 | |||||||
| 2019-01-31 | -556.00K GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -1.88M GBP derived: sum of 2 quarters · filed 2020-04-30 | -784.00K GBP derived: sum of 3 quarters · filed 2020-04-30 | -2.21M GBP 20-F · filed 2020-04-30 | -2.22M GBP 20-F · filed 2019-03-29 | |||
| 2018-10-31 | -1.33M GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | -228.00K GBP derived: sum of 2 quarters · filed 2019-12-17 | -1.65M GBP 6-K · filed 2019-12-17 | -1.66M GBP 6-K · filed 2018-12-11 | -7.81M GBP derived: sum of 4 quarters · filed 2020-04-30 | |||
| 2018-07-31 | 1.10M GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | -327.00K GBP 6-K · filed 2019-10-11 | -336.00K GBP 6-K · filed 2018-09-20 | -6.49M GBP derived: sum of 3 quarters · filed 2020-04-30 | -8.92M GBP derived: sum of 4 quarters · filed 2020-04-30 | |||
| 2018-04-30 | -1.43M GBP 6-K · filed 2019-06-12 | -7.58M GBP derived: sum of 2 quarters · filed 2020-04-30 | -10.02M GBP derived: sum of 3 quarters · filed 2020-04-30 | |||||
| 2018-01-31 | -6.16M GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -8.60M GBP derived: sum of 2 quarters · filed 2020-04-30 | -8.95M GBP 20-F · filed 2020-04-30 | -8.99M GBP 20-F · filed 2019-03-29 | ||||
| 2017-10-31 | -2.44M GBP derived: 6-K 9 month − 6-K 6 month · filed 2018-12-11 | -2.79M GBP 6-K · filed 2018-12-11 | ||||||
| 2017-07-31 | -351.00K GBP 6-K · filed 2018-09-20 | |||||||
| 2017-01-31 | 492.00K GBP 20-F · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |